Structural insight into binding site access and ligand recognition by human ABCB1
Devanshu KurreiD, Phuoc Xuan DangiD, Le Thi My LeiD, Varun V. GadkariiD, Amer AlamiD
Abstract
ABCB1 is a broad-spectrum efflux pump central to cellular drug handling and multidrug resistance in humans. However, its mechanisms of poly-specific substrate recognition and transport remain poorly resolved. Here we present cryo-EM structures of lipid embedded human ABCB1 in its apo, substrate-bound, inhibitor-bound, and nucleotide-trapped states at 3.4-3.9 [A] resolution without using stabilizing antibodies or mutations and each revealing a distinct conformation. The substrate binding site is located within one half of the molecule and, in the apo state, is obstructed by transmembrane helix (TM) 4. Substrate and inhibitor binding are distinguished by major differences in TM arrangement and ligand binding chemistry, with TM4 playing a central role in all conformational transitions. Our data offer fundamental new insights into the role structural asymmetry, secondary structure breaks, and lipid interactions play in ABCB1 function and have far-reaching implications for ABCB1 inhibitor design and predicting its substrate binding profiles.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 25
- FWCI
- 10.22
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis of substrate recognition and translocation by human ABCA4
- Capturing the interplay of membrane lipids and structural transitions in human ABCA7
L. T. M. Le, J. R. Thompson, … A. Alam·bioRxiv·Mar 1, 2021
- Structural basis of substrate recognition and translocation by human ABCD1
- Cryo-EM structure of an elusive pre-transport intermediate of the multidrug transporter BmrCD reveals modes of asymmetric drug binding
T. M. Thaker, S. Mishra, … T. M. Tomasiak·bioRxiv·Mar 13, 2021
- Structure of ABCB1/P-glycoprotein bound to the CFTR potentiator ivacaftor.
A. Barbieri, N. Thonghin, … R. C. Ford·bioRxiv·Jun 11, 2021
- Novel features in the structure of P-glycoprotein (ABCB1) in the post-hydrolytic state as determined at 7.9A resolution
N. Thongin, R. F. Collins, … R. C. Ford·bioRxiv·Apr 25, 2018